Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Commercial Biotechnology Separation Systems Market Size, Share, and Global Forecast, 2026-2032 | AI, Automation, and Single-Use Platforms Drive 12.58% CAGR to USD 76.41 Billion

globenewswire.com
A Agilent Technologies is listed as a company profile in a report on the commercial biotechnology separation systems market, indicating its potential involvement in this sector. The article does not provide specific sentiment towards the company. BDX Becton, Dickinson and Company is listed as a company profile in a report on the commercial biotechnology separation systems market, indicating its potential involvement in this sector. The article does not provide specific sentiment towards the company. BIO Bio-Rad Laboratories, Inc. is listed as a company profile in a report on the commercial biotechnology separation systems market, indicating its potential involvement in this sector. The article does not provide specific sentiment towards the company. DHR Danaher Corporation is listed as a company profile in a report on the commercial biotechnology separation systems market, indicating its potential involvement in this sector. The article does not provide specific sentiment towards the company. GEHC GE HealthCare Technologies Inc. is listed as a company profile in a report on the commercial biotechnology separation systems market, indicating its potential involvement in this sector. The article does not provide specific sentiment towards the company. ILMN Illumina, Inc. is listed as a company profile in a report on the commercial biotechnology separation systems market, indicating its potential involvement in this sector. The article does not provide specific sentiment towards the company. QGEN QIAGEN N.V. is listed as a company profile in a report on the commercial biotechnology separation systems market, indicating its potential involvement in this sector. The article does not provide specific sentiment towards the company. RGEN Repligen Corporation is listed as a company profile in a report on the commercial biotechnology separation systems market, indicating its potential involvement in this sector. The article does not provide specific sentiment towards the company. TMO Thermo Fisher Scientific Inc. is listed as a company profile in a report on the commercial biotechnology separation systems market, indicating its potential involvement in this sector. The article does not provide specific sentiment towards the company. WTRG Waters Corporation is listed as a company profile in a report on the commercial biotechnology separation systems market, indicating its potential involvement in this sector. The article does not provide specific sentiment towards the company.

Commercial Biotechnology Separation Systems Market Size, Share, and Global Forecast, 2026-2032 | AI, Automation, and Single-Use Platforms Drive 12.58% CAGR to USD 76.41 Billion Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Commercial Biotechnology Separation Systems Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

The commercial biotechnology separation systems market research report provides strategic analysis of the technologies, applications, operational priorities, and regional dynamics shaping this rapidly expanding industry. The market is projected to reach USD 37.43 billion in 2026 and grow at a compound annual growth rate (CAGR) of 12.58% to USD 76.41 billion by 2032. Its findings support strategic planning by highlighting opportunities in scalable purification, process automation, and data-enabled biomanufacturing.

Market Overview

Commercial biotechnology separation systems enable the recovery, purification, concentration, and polishing of biological products across biopharmaceutical manufacturing, diagnostics, food biotechnology, industrial biotechnology, and research workflows.

Key technology categories include:

Demand is rising as manufacturers pursue reproducible quality, efficient material use, regulatory compliance, and scalable production.

Process Intensification and Quality-by-Design

The market is moving from isolated unit operations toward integrated, automated, and data-rich downstream processes. Single-use equipment, continuous processing, high-throughput screening, modular platforms, and intensified purification can reduce changeover requirements, shorten production cycles, and improve facility flexibility.

Stricter expectations for traceability, contamination control, validation, and consistent product quality are also accelerating the adoption of process analytical technology and standardized operating procedures. These insights allow decision-makers to compare platform investments against production economics, compliance requirements, and long-term capacity needs.

Artificial Intelligence in Separation Systems

Artificial intelligence is becoming increasingly relevant to system development and operation through:

Effective deployment depends on reliable data governance, validated models, explainability, cybersecurity, and human oversight. AI is therefore best positioned as a decision-support layer within qualified workflows rather than a replacement for process expertise or regulatory controls.

Regional Market Insights

Regional comparisons provide a practical basis for evaluating market-entry strategies, supply-chain exposure, and localized service requirements.

Economic Group and Country Dynamics

ASEAN markets are strengthening cross-border manufacturing and healthcare supply chains, while BRICS economies emphasize domestic capability, technology transfer, and resilience. The European Union prioritizes harmonized regulation and sustainability; G7 economies support advanced automation and high-value biologics; and GCC countries are investing in biotechnology diversification.

Major markets differ in their adoption priorities:

Strategic Priorities for Industry Leaders

Key Takeaways from This Report

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. New Revenue Opportunities

3.4. Next-Generation Business Models

3.5. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Commercial Biotechnology Separation Systems Market, by Product Type

7.1. Introduction

7.2. Consumables

7.3. Instruments

7.3.1. Centrifugation Systems

7.3.2. Chromatography Systems

7.3.2.1. Preparative Chromatography

7.3.2.2. Process Chromatography

7.3.3. Electrophoresis Systems

7.3.4. Filtration Systems

7.4. Services

8. Commercial Biotechnology Separation Systems Market, by Technology

8.1. Introduction

8.2. Centrifugation

8.3. Chromatography

8.3.1. Affinity Chromatography

8.3.2. Ion Exchange Chromatography

8.3.2.1. Anion Exchange

8.3.2.2. Cation Exchange

8.3.3. Membrane Chromatography

8.3.4. Size Exclusion Chromatography

8.4. Electrophoresis

8.5. Filtration

9. Commercial Biotechnology Separation Systems Market, by Application

9.1. Introduction

9.2. Academic Research

9.3. Biopharmaceutical Production

9.3.1. Cell And Gene Therapies

9.3.2. Monoclonal Antibodies

9.3.3. Recombinant Proteins

9.3.4. Vaccines

9.4. Diagnostics

9.4.1. Clinical Diagnostics

9.4.2. Point Of Care

9.4.3. Research Diagnostics

9.5. Environmental Testing

9.6. Food And Beverage Testing

10. Commercial Biotechnology Separation Systems Market, by End User

10.1. Introduction

10.2. Academic And Research Institutes

10.3. Biotechnology Companies

10.4. CROs

10.5. Pharmaceutical Companies

10.5.1. Large Pharmaceutical Companies

10.5.2. Small And Mid-Size Pharmaceutical Companies

11. Commercial Biotechnology Separation Systems Market, by Region

11.1. Introduction

11.2. Asia-Pacific

11.3. North America

11.4. Latin America

11.5. Europe

11.6. Middle East

11.7. Africa

12. Commercial Biotechnology Separation Systems Market, by Group

12.1. Introduction

12.2. ASEAN

12.3. GCC

12.4. European Union

12.5. BRICS

12.6. G7

12.7. NATO

13. Commercial Biotechnology Separation Systems Market, by Country

13.1. Introduction

13.2. United States

13.3. Canada

13.4. Mexico

13.5. Brazil

13.6. United Kingdom

13.7. Germany

13.8. France

13.9. Russia

13.10. Italy

13.11. Spain

13.12. China

13.13. India

13.14. Japan

13.15. Australia

13.16. South Korea

14. Competitive Landscape

14.1. Market Share Analysis, 2025

14.2. Market Concentration Analysis, 2025

14.2.1. Concentration Ratio (CR)

14.2.2. Herfindahl Hirschman Index (HHI)

14.3. Recent Developments & Impact Analysis, 2025

14.4. Product Portfolio Analysis, 2025

14.5. Benchmarking Analysis, 2025

15. Company Profiles

15.1. Agilent Technologies, Inc.

15.2. Alfa Laval AB

15.3. Becton, Dickinson and Company

15.4. Bio-Rad Laboratories, Inc.

15.5. bioMerieux SA

15.6. Danaher Corporation

15.7. DiaSorin S.p.A.

15.8. GE HealthCare Technologies Inc.

15.9. GL Sciences Inc.

15.10. Hitachi, Ltd.

15.11. Illumina, Inc.

15.12. JASCO International Co., Ltd.

15.13. LECO Corporation

15.14. Merck KGaA

15.15. Miltenyi Biotec B.V. & Co. KG

15.16. Novasep Holding SAS

15.17. QIAGEN N.V.

15.18. Repligen Corporation

15.19. Sartorius AG

15.20. Shimadzu Corporation

15.21. Thermo Fisher Scientific Inc.

15.22. Tosoh Corporation

15.23. Waters Corporation

16. Key Experts

LIST OF FIGURES [19]

LIST OF TABLES [305]

For more information about this report visit https://www.researchandmarkets.com/r/n9jmrk

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.